Predictors of clinical response and remission at 1 year among a multicenter cohort of patients with inflammatory bowel disease treated with vedolizumab

Digestive Diseases and Sciences

from Gastroenterology via xlomafota13 on Inoreader http://ift.tt/2rTqhD9
via IFTTT